Skip to content
Home » Insights » What Really Drives Change in Clinical Practice in Ophthalmology?

What Really Drives Change in Clinical Practice in Ophthalmology?

What Drives Change

In ophthalmology, change doesn’t happen overnight. Surgeons rarely adopt a new instrument, technique, or therapy based solely on a single congress presentation or a polished marketing campaign. Instead, practice evolves gradually — influenced by a combination of evidence, peer trust, practical enablers, and access to care.

Over the years, working alongside ophthalmologists, industry partners, and professional societies, I’ve seen how often companies confuse visibility with influence. A packed symposium or a high-profile keynote may look like success, but the true drivers of adoption are more nuanced — and ultimately more powerful.

At a busy congress, clinicians are inundated with data and messaging. Unless information is reinforced and contextualized, even the strongest session risks being forgotten amid the noise. Real change occurs when insights are sustained through peer discussion, practical application, and consistent advocacy long after the event ends.

Evidence as the Foundation

Robust clinical evidence remains the cornerstone of meaningful change in ophthalmology. Surgeons want convincing proof of improved safety, efficacy, or efficiency. Peer-reviewed publications are still the gold standard, but real-world evidence has become increasingly critical. Clinicians seek reassurance that results extend beyond controlled trials and reflect the complexity of daily patient care.

The pitfall comes when companies assume that publishing data is enough. In reality, evidence must be explained, contextualized, and made relevant to the everyday decisions surgeons face. Comparative data and inclusion in guidelines are what transform an innovation from “interesting” into “essential.”

The Influence of Trusted Peers

Ophthalmology thrives on community, and peer-to-peer influence often carries more weight than any single dataset. Surgeons look not only at results, but also at how colleagues they respect are applying new approaches.

While global key opinion leaders have their place, it is often national or regional champions who drive adoption locally. A respected trainer demonstrating a technique in theatre, or sharing insights in a wet lab, can have a ripple effect through their fellows and networks. Even informal peer exchanges — at meetings, webinars, or in professional WhatsApp groups — shape practice more than promotional efforts.

The credibility gap lies in assuming that only the biggest podium voices matter. Influence is not always visible. Often, it is the colleague who trains tomorrow’s surgeons or the trusted local educator whose endorsement shifts practice most effectively.

Practical Enablers of Adoption

Even with strong evidence and peer endorsement, innovations falter if they are difficult to integrate into daily practice. Surgeons carefully weigh practical enablers such as:

  • Learning curve: Techniques that are intuitive, safe, and backed by structured training are adopted faster.
  • Compatibility: Innovations that fit seamlessly into existing workflows, theatre setups, and procurement systems are more appealing.
  • Sustained support: Proctoring, mentoring, and accessible digital resources help build lasting confidence.

Learning science reinforces this point. Ebbinghaus’s forgetting curve shows that without reinforcement, most newly learned information fades within days. The same applies to clinical adoption. A one-off symposium may spark interest, but without structured follow-up, the knowledge seldom translates into routine practice.

The common misstep is equating interest with adoption. Sustained reinforcement and multiple touchpoints are essential for lasting change.

The Role of Access and Reimbursement

Even the most compelling innovation can stall without clear economic and structural pathways. Hospital procurement teams act as gatekeepers for instruments and devices, while reimbursement and coding frameworks determine financial viability for hospitals and surgeons alike.

Increasingly, decision-makers also weigh cost efficiency and sustainability. Solutions that align with both clinical benefit and economic priorities are far more likely to win approval.

The mistake is assuming that clinician enthusiasm alone can drive adoption. Without access, procurement approval, and reimbursement clarity, even highly motivated surgeons face barriers that enthusiasm cannot overcome.

The Interplay of Drivers

Sustainable change in ophthalmology happens only when four elements align:

  1. Credible evidence
  2. Trusted peer influence
  3. Practical enablers
  4. Favorable access and reimbursement

If one element is missing, momentum stalls. But when all four converge, ophthalmologists are empowered to adopt new approaches with confidence.

At ArtiaCo. we believe advocacy must be built on these fundamentals. True impact isn’t about visibility or noise — it’s about credibility, timing, and alignment with real-world decision-making. When done well, advocacy becomes more than influence: it becomes a catalyst for sustainable change and, most importantly, better outcomes for patients.

Robby Palmer - Robby Palmer is a strategic leader in ophthalmology with over 20 years of global experience in clinical education, KOL engagement, and product strategy. As Co-Founder of ArtiaCo. Robby helps bridge the gap between industry and ophthalmic innovators — championing advocacy, representation and smart collaboration to drive meaningful progress in eye care. Throughout his career, Robby has built and led global KOL networks, launched next-generation training platforms, and guided the development of scalable, compliant engagement models. His work is grounded in a commitment to quality partnership, diversity and innovation — core values that define ArtiaCo’s mission to support the future of ophthalmology.